| |
| |
|
| Insider
Information: |
Treco Douglas A |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
22,665 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$107,620 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
22,665 |
|
|
| Total
Value |
$107,620 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ra Pharmaceuticals, Inc. |
RARX |
President and CEO, Dir... |
2020-04-02 |
0 |
|
0 |
Premium* |
|
|
Crispr Therapeutics Ag |
CRSP |
Director |
2020-06-11 |
2,000 |
|
0 |
Premium* |
|
|
Inozyme Pharma, Inc. |
INZY |
|
2024-04-02 |
20,665 |
2024-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INZY |
Inozyme Pharma, Inc. |
CEO |
• • – |
2024-04-02 |
4 |
S |
$6.94 |
$52,210 |
D/D |
(7,523) |
20,665 |
0 |
- |
|
| INZY |
Inozyme Pharma, Inc. |
CEO |
• • – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,000 |
28,188 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2020-06-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,000 |
|
% |
|
| RARX |
Ra Pharmaceuticals, Inc. |
President and CEO |
• • – |
2020-04-02 |
4 |
D |
$48.00 |
$11,265,936 |
D/D |
(234,707) |
0 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
President and CEO |
• • – |
2019-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,834 |
225,126 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
President and CEO |
• • – |
2019-02-01 |
4 |
D |
$21.00 |
$132,867 |
D/D |
(6,327) |
218,799 |
0 |
- |
|
| RARX |
Ra Pharmaceuticals, Inc. |
President & CEOOfficer |
• • – |
2016-10-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
204,292 |
|
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
